comparemela.com

Latest Breaking News On - Insider transactions at eyepoint pharmaceuticals - Page 1 : comparemela.com

Chardan Capital Comments on EyePoint Pharmaceuticals, Inc.'s FY2025 Earnings (NASDAQ:EYPT)

Chardan Capital Comments on EyePoint Pharmaceuticals, Inc.'s FY2025 Earnings (NASDAQ:EYPT)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Switzerland
California
United-states
Essex
Swiss
Eyepoint-pharmaceuticals-inc
Insider-transactions-at-eyepoint-pharmaceuticals
Nasdaq
Institutional-investors-weigh-in-on-eyepoint-pharmaceuticals
Proshare-advisors
Legacy-capital-group-california-inc

EyePoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Passes Above Two Hundred Day Moving Average of $17.27

EyePoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Passes Above Two Hundred Day Moving Average of $17.27
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Darioa-paggiarino
Deutsche-bank
Tower-research-capital
Insider-transactions-at-eyepoint-pharmaceuticals
Nasdaq
Securities-exchange-commission
Jpmorgan-chase-co
American-international-group-inc
Eyepoint-pharmaceuticals-inc

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Average Rating of "Buy" from Analysts

Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) have received a consensus recommendation of “Buy” from the six analysts that are presently covering the stock, MarketBeat reports. Six investment analysts have rated the stock with a buy rating. The average twelve-month target price among brokerages that have issued a report on the stock […]

Insider-transactions-at-eyepoint-pharmaceuticals
Schonfeld-strategic-advisors
Toth-financial-advisory-corp
News-ratings-for-eyepoint-pharmaceuticals-daily
Barclays-plc
Nasdaq
Eyepoint-pharmaceuticals
Cantor-fitzgerald
Lazard-asset-management
Eyepoint-pharmaceuticals-inc
Tower-research-capital

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up to $19.15

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up to $19.15
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
American
News-ratings-for-eyepoint-pharmaceuticals-daily
Cubist-systematic-strategies
Eyepoint-pharmaceuticals-inc
Eyepoint-pharmaceuticals
Charles-schwab-investment-management-inc
Royal-bank
American-international-group-inc
Securities-exchange-commission

vimarsana © 2020. All Rights Reserved.